Key result
Electroconvulsive therapy effectively treated malignant catatonia/neuroleptic malignant syndrome in a 17-year-old female after a 6-week delay in diagnosis.
Why the study?
Does electroconvulsive therapy (ECT) effectively treat malignant catatonia/neuroleptic malignant syndrome in an adolescent?
Case Report (n=1)
Does electroconvulsive therapy (ECT) effectively treat malignant catatonia/neuroleptic malignant syndrome in an adolescent?
Electroconvulsive therapy (ECT) can be an effective treatment for malignant catatonia/neuroleptic malignant syndrome in adolescents, highlighting the importance of early recognition to avoid delayed treatment.
Answers are grounded in this paper and cite their sources.
ECT may benefit adolescents with delayed-diagnosis malignant catatonia/NMS; leaves open need for prospective data before practice change.
A 17-year-old adolescent female presented to a psychiatric emergency room with excitement, confusion, and psychotic symptoms. After brief exposure to haloperidol and olanzapine, she developed fever, rigidity, waxy flexibility, autonomic instability, and elevated creatinine phosphokinase enzyme. Approximately 6 weeks after the onset of the illness, multiple laboratory tests, and evaluation at three different hospitals, the condition was effectively treated with electroconvulsive therapy (ECT). This case is a lesson in delayed recognition and the delayed use of ECT for the malignant catatonia/neuroleptic malignant syndrome.
No takes yet. Share an insight, caveat, or question.
Ghaziuddin et al. (2002) conducted a case report in Malignant catatonia/neuroleptic malignant syndrome (n=1). Electroconvulsive therapy (ECT) was evaluated on Clinical improvement. Electroconvulsive therapy effectively treated malignant catatonia/neuroleptic malignant syndrome in a 17-year-old female after a 6-week delay in diagnosis.
Synapse has enriched 10 related papers. Consider them for comparative context: